Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-03 Sale | 2025-10-07 6:26 pm | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Executive Officer | 1,620 | $18.75 | $30,375 | 188,916 (Direct) | View |
| 2025-08-28 Sale | 2025-09-11 1:55 pm | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 11,120 | $17.49 | $194,489 | 44,215 (Direct) | View |
| 2025-03-14 Purchase | 2025-03-19 7:40 pm | OptimizeRx Corp | OPRX | Lang James Paul Director | 321,408 | $7.6033 | $2,443,761 | 389,452 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-21 Option Award | 2025-11-10 09:55 am | N/A 2030-08-21 | OptimizeRx Corp | OPRX | Merrell Brendan W. CHIEF OPERATING OFFICER | 33,854 | $0 | 74,082 (Direct) | View |
| 2025-10-03 Tax Withholding | 2025-11-10 09:55 am | N/A N/A | OptimizeRx Corp | OPRX | Merrell Brendan W. CHIEF OPERATING OFFICER | 483 | $18.75 | 74,082 (Direct) | View |
Ownership | 2025-11-10 09:55 am | N/A N/A | OptimizeRx Corp | OPRX | Merrell Brendan W. CHIEF OPERATING OFFICER | 0 | $0 | 67,144 (Direct) | View |
| 2025-10-01 Tax Withholding | 2025-11-07 5:51 pm | N/A N/A | OptimizeRx Corp | OPRX | D'Silva Andrew J. Chief Business Officer | 414 | $18.98 | 46,306 (Direct) | View |
| 2025-10-03 Tax Withholding | 2025-11-07 5:51 pm | N/A N/A | OptimizeRx Corp | OPRX | D'Silva Andrew J. Chief Business Officer | 794 | $18.75 | 46,306 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-03 8:12 pm | N/A N/A | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 1,693 | $20.49 | 74,288 (Direct) | View |
| 2025-10-03 Tax Withholding | 2025-10-07 6:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal & Admin Officer | 1,952 | $18.75 | 90,598 (Direct) | View |
| 2025-10-03 Exercise | 2025-10-07 6:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal & Admin Officer | 6,649 | $0 | 90,598 (Direct) | View |
| 2025-10-03 Exercise | 2025-10-07 6:26 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Executive Officer | 6,649 | $0 | 188,916 (Direct) | View |
| 2025-10-03 Tax Withholding | 2025-10-07 6:25 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward Chief Finance & Strat Officer | 4,406 | $18.75 | 122,981 (Direct) | View |
| 2025-10-03 Exercise | 2025-10-07 6:25 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward Chief Finance & Strat Officer | 16,623 | $0 | 122,981 (Direct) | View |
| 2025-10-03 Tax Withholding | 2025-10-07 5:52 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product & Tech Officer | 983 | $18.75 | 69,572 (Direct) | View |
| 2025-10-03 Exercise | 2025-10-07 5:52 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product & Tech Officer | 3,325 | $0 | 69,572 (Direct) | View |
| 2025-08-21 Option Award | 2025-10-07 11:26 am | N/A 2030-08-21 | OptimizeRx Corp | OPRX | D'Silva Andrew J. Chief Business Officer | 33,854 | $0 | 70,951 (Direct) | View |
Ownership | 2025-10-07 11:25 am | N/A N/A | OptimizeRx Corp | OPRX | D'Silva Andrew J. Chief Business Officer | 0 | $0 | 116,723 (Direct) | View |
| 2025-08-21 Option Award | 2025-08-25 4:32 pm | 2026-08-21 2030-08-21 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Executive Officer | 50,781 | $0 | 219,043 (Direct) | View |
| 2025-08-21 Option Award | 2025-08-25 4:29 pm | 2026-08-21 2030-08-21 | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal & Admin Officer | 50,781 | $0 | 121,057 (Direct) | View |
| 2025-08-21 Option Award | 2025-08-25 3:21 pm | 2026-08-21 2030-08-21 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 50,781 | $0 | 145,920 (Direct) | View |
| 2025-08-21 Option Award | 2025-08-25 3:17 pm | 2026-08-21 2030-08-21 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 50,781 | $0 | 111,137 (Direct) | View |
| 2025-08-21 Option Award | 2025-08-25 3:16 pm | 2026-08-21 2030-08-21 | OptimizeRx Corp | OPRX | Besch Doug Chief Prod & Tech Officer | 50,781 | $0 | 102,386 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:36 pm | N/A N/A | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 9,868 | $0 | 21,620 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:35 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 9,868 | $0 | 399,320 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:34 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 9,868 | $0 | 55,335 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:33 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 9,868 | $0 | 72,642 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:31 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 9,868 | $0 | 57,183 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 4:04 pm | 2026-05-15 2028-05-15 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 21,616 | $0 | 72,489 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 4:03 pm | 2026-05-15 2029-05-15 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 127,832 | $0 | 249,146 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 09:18 am | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 572 | $5.18 | 121,314 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 09:18 am | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,928 | $0 | 121,314 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 09:16 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 268 | $5.18 | 70,276 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 09:16 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 771 | $0 | 70,276 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-20 1:40 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 401 | $6.64 | 600,852 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,156 | $6.64 | 95,139 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:39 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 1,386 | $6.64 | 51,605 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:39 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 2,298 | $6.64 | 119,958 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-20 1:38 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO | 1,479 | $6.64 | 69,773 (Direct) | View |
| 2025-02-11 Tax Withholding | 2025-02-13 3:58 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,386 | $5.6 | 83,252 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-13 3:58 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 83,252 (Direct) | View |
| 2025-02-02 Exercise | 2025-02-04 6:50 pm | 2025-02-02 2025-02-02 | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 5,109 | $0 | 11,752 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 5:00 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 119,150 | $0 | 175,037 (Direct) | View |
| 2024-02-15 Option Award(A) | 2024-12-27 4:38 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 0 | $0 | 33,365 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 3:18 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 119,150 | $0 | 199,998 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:09 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 44,681 | $0 | 80,026 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:08 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 119,150 | $0 | 146,380 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-27 2:08 pm | 2025-12-23 2027-12-23 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 119,150 | $0 | 130,733 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-20 7:48 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,153 | $4.75 | 35,086 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 7:48 pm | 2024-12-19 2026-12-19 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 3,927 | $0 | 35,086 (Direct) | View |